121 related articles for article (PubMed ID: 2399726)
21. Plasma levels of endothelin-1 in patients with Crohn's disease and ulcerative colitis.
Letizia C; Boirivant M; De Toma G; Cerci S; Subioli S; Scuro L; Ferrari P; Pallone F
Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):266-9. PubMed ID: 9759593
[TBL] [Abstract][Full Text] [Related]
22. [Incidence of inflammatory bowel diseases in Bretagne (1994-1995). ABERMAD. Association Bertonne d'Etude et de Recherche des Maladies de l'Appareil Digesif].
Pagenault M; Tron I; Alexandre JL; Cruchant E; Dabadie A; Chaperon J; Robaszkiewicz M; Bretagne JF
Gastroenterol Clin Biol; 1997; 21(6-7):483-90. PubMed ID: 9295976
[TBL] [Abstract][Full Text] [Related]
23. The leukocyte count predicts the efficacy of treatment with azathioprine in inflammatory bowel disease.
Glas J; Török HP; Daczo J; Tonenchi L; Folwaczny M; Folwaczny C
Eur J Med Res; 2005 Dec; 10(12):535-8. PubMed ID: 16356870
[TBL] [Abstract][Full Text] [Related]
24. [The usefulness of reactive protein C in managing patients with ulcerative colitis and Crohn's disease].
López Morante AJ; Sáez-Royuela F; Yuguero del Moral L; Martín Lorente JL; Ojeda Giménez C
Rev Esp Enferm Dig; 1993 Jan; 83(1):5-9. PubMed ID: 8452705
[TBL] [Abstract][Full Text] [Related]
25. Antigen specificity of circulating anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease.
Kossa K; Coulthart A; Ives CT; Pusey CD; Hodgson HJ
Eur J Gastroenterol Hepatol; 1995 Aug; 7(8):783-9. PubMed ID: 7496870
[TBL] [Abstract][Full Text] [Related]
26. Defense mechanisms in inflammatory bowel disease.
Hyphantis TN; Triantafillidis JK; Pappa S; Mantas C; Kaltsouda A; Cherakakis P; Alamanos Y; Manousos ON; Mavreas VG
J Gastroenterol; 2005 Jan; 40(1):24-30. PubMed ID: 15692786
[TBL] [Abstract][Full Text] [Related]
27. [Reconstructive surgery in patients with nonspecific ulcerative colitis and Crohn disease].
Fedorov VD; Oleĭnikov PN; Alip'ev VIu
Khirurgiia (Mosk); 1989 Oct; (10):74-7. PubMed ID: 2593580
[TBL] [Abstract][Full Text] [Related]
28. Cold-reactive lymphocytotoxins in Crohn's disease and ulcerative colitis. I. Incidence and characterization.
Brown DJ; Jewell DP
Clin Exp Immunol; 1982 Jul; 49(1):67-74. PubMed ID: 6982133
[TBL] [Abstract][Full Text] [Related]
29. [Incidence of inflammatory bowel diseases in the department of Puy-de-Dôme in 1993 and 1994. EPIMICI. Epidémiologie des Maladies Inflammatoires Cryptogenetiques de l'Intestin group].
Flamenbaum M; Zénut M; Aublet-Cuvelier B; Larpent JL; Fabre P; Abergel A; Dapoigny M; Bommelaer G
Gastroenterol Clin Biol; 1997; 21(6-7):491-6. PubMed ID: 9295977
[TBL] [Abstract][Full Text] [Related]
30. Anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease: do they recognize different subsets of a heterogeneous disease?
Castellino F; Rosina F; Bansi DS; Bauducci M; Touscoz GA; Giorda L; Borghesio E; Bessone MP; Astegiano M; Musso A
Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):859-64. PubMed ID: 8574718
[TBL] [Abstract][Full Text] [Related]
31. Abnormalities of fasting serum concentrations of peptide YY in the idiopathic inflammatory bowel diseases.
Koch TR; Roddy DR; Go VL
Am J Gastroenterol; 1987 Apr; 82(4):321-6. PubMed ID: 3565336
[TBL] [Abstract][Full Text] [Related]
32. [Diagnostic and therapeutic implications of allergic processes in Crohn's disease and ulcerative colitis (author's transl)].
Tschaikowski KL; Jorde W
Leber Magen Darm; 1979 Dec; 9(6):294-8. PubMed ID: 547140
[TBL] [Abstract][Full Text] [Related]
33. [Hyperbaric oxygenation and drug therapy in treatment of nonspecific ulcerative colitis and Crohn's disease].
Poliakova LV; Lukich VL; Grigor'eva GA
Fiziol Zh (1978); 1991; 37(5):120-3. PubMed ID: 1790809
[TBL] [Abstract][Full Text] [Related]
34. Diminished neutrophil function in Crohn's disease and ulcerative colitis identified by decreased oxidative metabolism and low superoxide dismutase content.
Verspaget HW; Peña AS; Weterman IT; Lamers CB
Gut; 1988 Feb; 29(2):223-8. PubMed ID: 2831119
[TBL] [Abstract][Full Text] [Related]
35. Immunological studies on Crohn's disease. VIII. Diminished phagocytic activity in peripheral blood monocytes.
Okabe N; Ikura S; Uchida Y; Fujita K; Yao T
J Clin Lab Immunol; 1990 May; 32(1):29-31. PubMed ID: 1967033
[TBL] [Abstract][Full Text] [Related]
36. Lysozyme in plasma and neutrophilic granulocytes in ulcerative colitis and Crohn's disease.
Koldkjaer O; Klitgaard NA; Schmidt KG
Scand J Gastroenterol; 1977; 12(2):135-40. PubMed ID: 847381
[TBL] [Abstract][Full Text] [Related]
37. Skin reactivity and phagocytic function of neutrophil leucocytes in Crohn's disease and ulcerative colitis.
Krause U; Michaëlsson G; Juhlin L
Scand J Gastroenterol; 1978; 13(1):71-5. PubMed ID: 635448
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the relationship between serum ghrelin, C-reactive protein and interleukin-6 levels, and disease activity in inflammatory bowel diseases.
Cekic C; Arabul M; Alper E; Pakoz ZB; Saritas E; Yuksel ; Ünsal B
Hepatogastroenterology; 2014; 61(133):1196-200. PubMed ID: 25436282
[TBL] [Abstract][Full Text] [Related]
39. Clq metabolism in ulcerative colitis and Crohn's disease.
Potter BJ; Hodgson HJ; Mee AS; Jewell DP
Gut; 1979 Nov; 20(11):1012-9. PubMed ID: 527870
[TBL] [Abstract][Full Text] [Related]
40. The nitroblue tetrazolium test in Crohn's disease and ulcerative colitis.
Ward M; Eastwood MA
Digestion; 1976; 14(2):179-83. PubMed ID: 950081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
